Unlike THC, the affinity of CBD for the CB1 and CB2 receptors is considered to be relatively low, although both CB1 and CB2 could still be the targets of CBD in certain cancer cells and in cells that infiltrate the TME [11,12,13,14,15,16,17]. The gene discussed is CNR2; the disease is cancer.